References

1. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult and childhood onset systemic lupus erythematosus: a comparaison of onset, clinical features, serology and outcome. Br J Rheumatol. 1995 ; 34(9): 866-72. PubMed | Google Scholar


2. Costallat LTL, Coimbra AMV. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol. 1994; 12(6): 603-7. PubMed | Google Scholar


3. Bader-Meunier B, Jeremiah N, Rieux-Laucat F. Le lupus systémique à début pédiatrique: une pathologie polygénique ou monogénique? Rev Med Interne. 2013; 34(4): 230-3. PubMed | Google Scholar


4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40 (9): 1725. PubMed | Google Scholar


5. Boccon-Gibod L, Just J, Grimfeld A, Tournier G. Familial pulmonary hemorrhage and lupus syndrome with C4 deficiency. Arch Anat Cytol Pathol. 1989 ; 37 (4): 177-180. PubMed | Google Scholar


6. Chapman RS, Meara RH. Infantile lupus erythematosus. Br J Dermatol. 1971; 84 (2):182-183. PubMed | Google Scholar


7. Jordan SC, Lemire JM, Border W, Sakai R, Ettenger RB, Fine RN. False-negative anti-DNA antibody activity in infantile systemic lupus erythematosus (SLE). J Clin Immunol. 1984; 4 (2): 156-162. PubMed | Google Scholar


8. Massengill SF, Richard GA, Donnelly WH. Infantile systemic lupus erythematosus with onset simulating congenital nephrotic syndrome. J Pediatr. 1994;124 (1): 27-31. PubMed | Google Scholar


9. Saberi MS, Jones BA. Remission of infantile systemic lupus erythematosus with intravenous cyclophosphamide. Pediatr Nephrol. 1998 ; 12 (2): 136-138. PubMed | Google Scholar


10. Ty A, Fine B. Membranous nephritis in infantile systemic lupus erythematosus associated with chromosomal abnormalities.Clin Nephrol. 1979; 12 (3): 137-141. PubMed | Google Scholar


11. Bader-Meunier B. Lupus systémique de l'enfant: actualités génétiques et thérapeutiques. La Revue de médecine interne. 2013 ; 34S : A7-A8. PubMed | Google Scholar


12. Belot A, Cimaz R. Le lupus de l'enfant à travers les âges. Revue du rhumatisme monographies. 2012; 79 (1): 24-29. PubMed | Google Scholar


13. Sève P, Ferry T, Charhon A, Calvet A, Broussolle C. Manifestations systémiques des infections à Parvovirus B19. Rev Med Interne. 2004; 25(10): 740-51. PubMed | Google Scholar


14. Tovari E, Mezey I, Hedman K, Czirjak L. Self limiting-like symptoms in patients with parvovirus B19 infection. Ann Rheum Dis. 2002;61 (7): 662-3. PubMed | Google Scholar


15. Kalt M, Gertner E. Antibodies to b2-Glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in Parvovirus B19 infection. J Rheumatol. 2001; 28 (10): 2335-6. PubMed | Google Scholar


16. Trapani S, Ermini M, Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.Semin Arthritis Rheum. 1999; 28 (5): 319-25. PubMed | Google Scholar


17. Shakoor N, Michalska M , Hanis CA, Block JA. Drud-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002; 359(9306): 579-80. PubMed | Google Scholar


18. Begue P, Quinet B, Leroy F, Baron S. Maladie de Kawasaki. Médecine et Maladies Infectieuses.1987; 17 (11 bis): 643- 650. PubMed | Google Scholar


19. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus complement deficiency and apoptosis. Adv Immunol. 2000; 76: 227-324. PubMed | Google Scholar